Clinical Trial Update: Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates the efficacy and safety of ultra-small-dose decitabine in lower-risk, transfusion-dependent myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine) (decitabine)

Snippet

Sponsor: Shandong University | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: UNKNOWN